Summary Favorable Q4 figures bring out optimism amongst investors New acquisitions and a new joint venture with Pfizer could lead to something huge Higher-than-average yield also comes with its share of uncertainty GlaxoSmithKline (GSK) has built over the years a pharmaceutical empire. R&D numbers reaching billions, new discoveries leading to newly marketed products as well […]
